Publication Cover
Biofouling
The Journal of Bioadhesion and Biofilm Research
Volume 31, 2015 - Issue 5
824
Views
28
CrossRef citations to date
0
Altmetric
Articles

Magnetic fields suppress Pseudomonas aeruginosa biofilms and enhance ciprofloxacin activity

, , , &
Pages 443-457 | Received 12 Mar 2015, Accepted 20 May 2015, Published online: 23 Jun 2015

References

  • Allaker RP. 2010. The use of nanoparticles to control oral biofilm formation. J Dent Res. 89:1175–1186.10.1177/0022034510377794
  • Anghel I, Grumezescu AM, Holban AM, Ficai A, Anghel AG, Chifiriuc MC. 2013. Biohybrid nanostructured iron oxide nanoparticles and Satureja hortensis to prevent fungal biofilm development. Int J Mol Sci. 14:18110–18123.10.3390/ijms140918110
  • Antoniani D, Bocci P, Maciag A, Raffaelli N, Landini P. 2010. Monitoring of diguanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for high-throughput screening of biofilm inhibitors. Appl Microbiol Biotechnol. 85:1095–1104.10.1007/s00253-009-2199-x
  • Anwar H, Strap JL, Costerton JW. 1992. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother. 36:1347–1351.10.1128/AAC.36.7.1347
  • Armijo LM, Brandt YI, Matthew D, Yadav S, Maestas S, Rivera AC, Cook NC, Withers NJ, Smolyakov GA, Adolphi NL, et al. 2012. Iron oxide nanocrystals for magnetic hyperthermia applications. Nanomaterials. 2:134–146.10.3390/nano2020134
  • Armijo LM, Brandt YI, Rivera AC, Cook NC, Plumley JB, Withers NJ, Kopciuch M, Smolyakov GA, Huber DL, Smyth HDC, et al. 2012. Multifunctional superparamagnetic nanoparticles for enhanced drug transport in cystic fibrosis. Nanosystems in Engineering and Medicine Proceedings of the SPIE. 8548:12. doi: 10.1117/12.943621.
  • Bajpai I, Basu B. 2013. Strategies to prevent bacterial adhesion on biomaterials. In Ramalingam M, Wang X, Chen G, Ma P, Cui F-Z, editors. Biomimetics: advancing nanobiomaterials and tissue engineering. Chapter 7. Hoboken (NJ): Wiley; p. 163–202.
  • Bandara HM, Harb A, Kolacny D Jr, Martins P, Smyth HD. 2014. Sound waves effectively assist Tobramycin in elimination of Pseudomonas aeruginosa biofilms in vitro. AAPS PharmSciTech. 15:1644–1654.10.1208/s12249-014-0200-1
  • Bandara HM, Lam OL, Watt RM, Jin LJ, Samaranayake LP. 2010. Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species. J Med Microbiol. 59:1225–1234.10.1099/jmm.0.021832-0
  • Bandara HM, Yau JY, Watt RM, Jin LJ, Samaranayake LP. 2010. Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development. BMC Microbiol. 10:125–133.10.1186/1471-2180-10-125
  • Banin E, Vasil ML, Greenberg EP. 2005. Iron and Pseudomonas aeruginosa biofilm formation. Proc Natl Acad Sci U S A. 102:11076–11081.10.1073/pnas.0504266102
  • Barraud N, Schleheck D, Klebensberger J, Webb JS, Hassett DJ, Rice SA, Kjelleberg S. 2009. Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J Bacteriol. 191:7333–7342.10.1128/JB.00975-09
  • Benson DE, Grissom CB, Burns GL, Mohammad SF. 1994. Magnetic field enhancement of antibiotic activity in biofilm forming Pseudomonas aeruginosa. ASAIO J. 40:M371–M376.10.1097/00002480-199407000-00025
  • Bjarnsholt T, Kirketerp-Moller K, Kristiansen S, Phipps R, Nielsen AK, Jensen PO, Hoiby N, Givskov M. 2007. Silver against Pseudomonas aeruginosa biofilms. APMIS. 115:921–928.10.1111/apm.2007.115.issue-8
  • Brown AN, Smith K, Samuels TA, Lu J, Obare SO, Scott ME. 2012. Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl Environ Microbiol. 78:2768–2774.10.1128/AEM.06513-11
  • Cai Y, Fan Y, Wang R, An MM, Liang BB. 2009. Synergistic effects of aminoglycosides and fosfomycin on Pseudomonas aeruginosa in vitro and biofilm infections in a rat model. J Antimicrob Chemother. 64:563–566.10.1093/jac/dkp224
  • Cassinelli C, Morra M, Pavesio A, Renier D. 2000. Evaluation of interfacial properties of hyaluronan coated poly(methylmethacrylate) intraocular lenses. J Biomater Sci Polym Ed.11:961–977.10.1163/156856200744138
  • Chen T, Wang R, Xu LQ, Neoh KG, Kang ET. 2012. Carboxymethyl chitosan-functionalized magnetic nanoparticles for disruption of biofilms of Staphylococcus aureus and Escherichia coli. Ind Eng Chem Res. 51:13164–13172.
  • Cirioni O, Giacometti A, Ghiselli R, Dell’Acqua G, Orlando F, Mocchegiani F, Silvestri C, Licci A, Saba V, Scalise G, et al. 2006. RNAIII-Inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter–associated Staphylococcus aureus infections. J Infect Dis. 15:180–186.10.1086/jid.2006.193.issue-2
  • CLSI. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 9th ed. Wayne (PA): Clinical and Laboratory Standards Institute [CLSI].
  • Corchero JL, Villaverde A. 2009. Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol. 27:468–476.10.1016/j.tibtech.2009.04.003
  • Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science. 284:1318–1322.10.1126/science.284.5418.1318
  • Cotar AI, Grumezescu AM, Andronescu E, Voicu G, Ficai A, Ou KL, Huang KS, Chifiriuc MC. 2013. Nanotechnological solution for improving the antibiotic efficiency against biofilms developed by Gram-negative bacterial strains. Lett Appl NanobioSci. 2:97–104.
  • Cui Y, Zhao Y, Tian Y, Zhang W, Lu X, Jiang X. 2012. The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli. Biomaterials. 33:2327–2333.10.1016/j.biomaterials.2011.11.057
  • Davies DG, Marques CN. 2009. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol. 191:1393–1403.10.1128/JB.01214-08
  • Di Poto A, Sbarra MS, Provenza G, Visai L, Speziale P. 2009. The effect of photodynamic treatment combined with antibiotic action or host defence mechanisms on Staphylococcus aureus biofilms. Biomaterials. 30:3158–3166.10.1016/j.biomaterials.2009.02.038
  • Durmus NG, Webster TJ. 2013. Eradicating antibiotic-resistant biofilms with silver-conjugated superparamagnetic iron oxide nanoparticles. Adv Healthc Mater. 2:165–171.10.1002/adhm.201200215
  • Ensing GT, Roeder BL, Nelson JL, Van Horn JR, Van der Mei HC, Busscher HJ, Pitt WG. 2005. Effect of pulsed ultrasound in combination with gentamicin on bacterial viability in biofilms on bone cements in vivo. J Appl Microbiol. 99:443–448.10.1111/jam.2005.99.issue-3
  • Fabrega J, Renshaw JC, Lead JR. 2009. Interactions of silver nanoparticles with Pseudomonas putida biofilms. Environ Sci Technol. 43:9004–9009.10.1021/es901706j
  • Francolini I, Donelli G. 2010. Prevention and control of biofilm-based medical-device-related infections. FEMS Immunol Med Microbiol. 59:227–238.
  • Francolini I, Norris P, Piozzi A, Donelli G, Stoodley P. 2004. Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob Agents Chemother. 48:4360–4365.10.1128/AAC.48.11.4360-4365.2004
  • Frederiksen B, Pressler T, Hansen A, Koch C, Hoiby N. 2006. Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis. Acta Paediatr. 95:1070–1074.10.1080/08035250600752466
  • Gao W, Liu Y, Zhou J, Pan H. 2005. Effects of a strong static magnetic field on bacterium Shewanella oneidensis: an assessment by using whole genome microarray. Bioelectromagnetics. 26:558–563.10.1002/(ISSN)1521-186X
  • Gindy ME, Prud’homme RK. 2009. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv. 6:865–878.10.1517/17425240902932908
  • Grosman Z, Kolar M, Tesarikova E. 1992. Effects of static magnetic field on some pathogenic microorganisms. Acta Univ Palacki Olomuc Fac Med. 134:7–9.
  • Gunawan P, Guan C, Song X, Zhang Q, Leong SS, Tang C, Chen Y, Chan-Park MB, Chang MW, Wang K, et al. 2011. Hollow fiber membrane decorated with Ag/MWNTs: toward effective water disinfection and biofouling control. ACS Nano. 5:10033–10040.10.1021/nn2038725
  • Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2:95–108.10.1038/nrmicro821
  • Haney C, Rowe JJ, Robinson JB. 2012. Spions increase biofilm formation by Pseudomonas aeruginosa. J Biomater Nanobiotechnol. 03:508–518.10.4236/jbnb.2012.324052
  • Harding MW, Marques LL, Howard RJ, Olson ME. 2009. Can filamentous fungi form biofilms? Trends Microbiol. 17:475–480.10.1016/j.tim.2009.08.007
  • Hart CA, Winstanley C. 2002. Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br Med Bull. 61:81–96.10.1093/bmb/61.1.81
  • Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006–2007. Infect Control Hosp Epidemiol. 29:996–1011.10.1086/595835
  • Hoiby N, Ciofu O, Bjarnsholt T. 2010. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol. 5:1663–1674.10.2217/fmb.10.125
  • Hoiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PO, Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T. 2011. The clinical impact of bacterial biofilms. Int J Oral Sci. 3:55–65.10.4248/IJOS11026
  • Hugh R, Leifson E. 1953. The taxonomic significance of fermentative versus oxidative metabolism of carbohydrates by various Gram negative bacteria. J Bacteriol. 66:24–26.
  • Johansson EM, Crusz SA, Kolomiets E, Buts L, Kadam RU, Cacciarini M, Bartels KM, Diggle SP, Camara M, Williams P, et al. 2008. Inhibition and dispersion of Pseudomonas aeruginosa biofilms by glycopeptide dendrimers targeting the fucose-specific lectin LecB. Chem Biol. 15:1249–1257.10.1016/j.chembiol.2008.10.009
  • Johannsen M, Gneveckow U, Taymoorian K, Thiesen B, Waldofner N, Scholz R, Jung K, Jordan A, Wust P, Loening SA. 2007. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. Int J Hyperthermia. 23:315–323.10.1080/02656730601175479
  • John T, Rajpurkar A, Smith G, Fairfax M, Triest J. 2007. Antibiotic pretreatment of hydrogel ureteral stent. J Endourol. 21:1211–1216.10.1089/end.2007.9904
  • Kafayati ME, Raheb J, Angazi MT, Alizadeh S, Bardania H. 2012. The effect of magnetic Fe3O4 nanoparticles on the growth of genetically manipulated bacterium, Pseudomonas aeruginosa (PTSOX4). Iran J Biotechnol. 11:41–46.
  • Kalishwaralal K, BarathManiKanth S, Pandian SR, Deepak V, Gurunathan S. 2010. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B. 79:340–344.10.1016/j.colsurfb.2010.04.014
  • Khoury AE, Lam K, Ellis B, Costerton JW. 1992. Prevention and control of bacterial infections associated with medical devices. ASAIO J. 38:M174–M178.10.1097/00002480-199207000-00013
  • Kim J, Pitts B, Stewart PS, Camper A, Yoon J. 2008. Comparison of the antimicrobial effects of chlorine, silver ion, and tobramycin on biofilm. Antimicrob Agents Chemother. 52:1446–1453.10.1128/AAC.00054-07
  • Kohno M, Yamazaki M, Kimura II, Wada M. 2000. Effect of static magnetic fields on bacteria: Streptococcus mutans, Staphylococcus aureus, and Escherichia coli. Pathophysiology. 7:143–148.10.1016/S0928-4680(00)00042-0
  • Kostenko V, Lyczak J, Turner K, Martinuzzi RJ. 2010. Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrob Agents Chemother. 54:5120–5131.10.1128/AAC.00825-10
  • Kvitek L, Soukupova J. 2009. Comment on ‘Preparation and antibacterial activity of Fe3O4@Ag nanoparticles’. Nanotechnology. 14:028001.10.1088/0957-4484/20/2/028001
  • Laszlo J, Kutasi J. 2010. Static magnetic field exposure fails to affect the viability of different bacteria strains. Bioelectromagnetics. 31:220–225.
  • Lee D, Cohen RE, Rubner MF. 2005. Antibacterial properties of Ag nanoparticle loaded multilayers and formation of magnetically directed antibacterial microparticles. Langmuir. 21:9651–9659.10.1021/la0513306
  • Lewis K. 2008. Multidrug tolerance of biofilms and persister cells. Curr Top Microbiol Immunol. 322:107–131.
  • Lipiec J, Janas P, Barabasz W. 2004. Effect of oscillating magnetic field pulses on the survival of selected microorganisms. Int Agrophysics. 18:325–328.
  • Liu S, Wei L, Hao L, Fang N, Chang MW, Xu R, Yang Y, Chen Y. 2009. Sharper and faster ‘nano darts’ kill more bacteria: a study of antibacterial activity of individually dispersed pristine single-walled carbon nanotube. ACS Nano. 3:3891–3902.10.1021/nn901252r
  • Lode H, Raffenberg M, Erbes R, Geerdes-Fenge H, Mauch H. 2000. Nosocomial pneumonia: epidemiology, pathogenesis, diagnosis, treatment and prevention. Curr Opin Infect Dis. 13:377–384.10.1097/00001432-200008000-00009
  • Lyczak JB, Cannon CL, Pier GB. 2000. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2:1051–1060.10.1016/S1286-4579(00)01259-4
  • Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. 2011. Protein−nanoparticle interactions: opportunities and challenges. Chem Rev. 111:5610–5637.10.1021/cr100440g
  • McGill SL, Cuylear C, Adolphi NL, Osinski M, Smyth HDC. 2009. Enhanced drug transport through alginate biofilms using magnetic nanoparticles. SPIE international symposium on biomedical optics BiOS. doi: 10.1117/12.816830.
  • McGowan JE Jr. 2006. Resistance in nonfermenting Gram-negative bacteria: multidrug resistance to the maximum. Am J Infect Control. 34: S29-37; discussion S64-73.
  • Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M. 2009. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 8:543–557.10.1038/nmat2442
  • Park H, Park HJ, Kim JA, Lee SH, Kim JH, Yoon J, Park TH. 2011. Inactivation of Pseudomonas aeruginosa PA01 biofilms by hyperthermia using superparamagnetic nanoparticles. J Microbiol Methods. 84:41–45.10.1016/j.mimet.2010.10.010
  • Piatti E, Albertini MC, Baffone W, Fraternale D, Citterio B, Piacentini MP, Dacha M, Vetrano F, Accorsi A. 2002. Antibacterial effect of a magnetic field on Serratia marcescens and related virulence to Hordeum vulgare and Rubus fruticosus callus cells. Comp Biochem Physiol B Biochem Mol Biol. 132:359–365.10.1016/S1096-4959(02)00065-9
  • Potenza L, Ubaldi L, De Sanctis R, De Bellis R, Cucchiarini L, Dacha M. 2004. Effects of a static magnetic field on cell growth and gene expression in Escherichia coli. Mutat Res. 561:53–62.10.1016/j.mrgentox.2004.03.009
  • Qi L, Xu Z, Jiang X, Hu C, Zou X. 2004. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res. 339:2693–2700.10.1016/j.carres.2004.09.007
  • Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R. 2007. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother. 51:1656–1660.10.1128/AAC.00350-06
  • Raghupathi KR, Koodali RT, Manna AC. 2011. Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir. 27:4020–4028.10.1021/la104825u
  • Rodrigues D, Bañobre-López M, Espiña B, Rivas J, Azeredo J 2012. Control of planktonic bacterial cells and biofilms through magnetic hyperthermia. Paper presented at: Biofilms 5 - International Conference Paris, France. 142–143. Available from: http://repositorium.sdum.uminho.pt/bitstream/1822/23908/5/205.pdf.
  • Romling U, Balsalobre C. 2012. Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med. 272:541–561.10.1111/joim.2012.272.issue-6
  • Saltzstein D, Wachs B, Perroncel R, Benson A, Herrington J, Haverstock D, Pertel P. 2007. Complicated urinary tract infections treated with extended-release ciprofloxacin with emphasis on Pseudomonas aeruginosa. J Chemother. 19:694–702.10.1179/joc.2007.19.6.694
  • Samaranayake LP. 2006. Essential microbiology for dentistry. Edinburgh: Churchill Livingstone.
  • Samarbaf-Zadeh AR, Moosavi R, Tahmasbi-Birgani MJ, Darki H. 2006. The effect of static electromagnetic field on cephalothin-resistant Pseudomonas aeroginosa. Jundishapur J Natural Pharm Prod. 1:13–17.
  • Sandvik EL. 2013. Electric current and magnetic field effects on bacterial biofilms [PhD Thesis]. Bozeman: Montana State University.
  • Schwartz E, Svejnochova M, Siposova E. 1989. Different effects of a weak static and a weak rotating magnetic field on the growth of mycobacteria. Bratisl Lek Listy. 90:787–792.
  • Soenen SJ, De Cuyper M. 2010. Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects. Nanomedicine (Lond). 5:1261–1275.10.2217/nnm.10.106
  • Stepanian RS, Barsegian AA, Alaverdian ZhR, Oganesian GG, Markosian LS, Airapetian SN. 2000. The effect of magnetic fields on the growth and division of the lon mutant of Escherichia coli K-12. Radiats Biol Radioecol. 40:319–322.
  • Subbiahdoss G, Sharifi S, Grijpma DW, Laurent S, van der Mei HC, Mahmoudi M, Busscher HJ. 2012. Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci. Acta Biomater. 8:2047–2055.10.1016/j.actbio.2012.03.002
  • Taylor EN, Kummer KM, Durmus NG, Leuba K, Tarquinio KM, Webster TJ. 2012. Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms. Small. 8:3016–3027.10.1002/smll.v8.19
  • Taylor EN, Webster TJ. 2009. The use of superparamagnetic nanoparticles for prosthetic biofilm prevention. Int J Nanomedicine. 4:145–152.
  • Ueda A, Attila C, Whiteley M, Wood TK. 2009. Uracil influences quorum sensing and biofilm formation in Pseudomonas aeruginosa and fluorouracil is an antagonist. Microb Biotechnol. 2:62–74.10.1111/mbt.2009.2.issue-1
  • Ungaro F, d’Angelo I, Coletta C, d’Emmanuele di Villa Bianca R, Sorrentino R, Perfetto B, Tufano MA, Miro A, La Rotonda MI, Quaglia F. 2012. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. J Control Release. 10:149–159.10.1016/j.jconrel.2011.08.010
  • van de Belt H, Neut D, Schenk W, van Horn JR, van der Mei HC, Busscher HJ. 2001. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review Acta Orthop Scand. 72:557–571.10.1080/000164701317268978
  • von Bismarck P, Schneppenheim R, Schumacher U. 2001. Successful treatment of Pseudomonas aeruginosa respiratory tract infection with a sugar solution-a case report on a lectin based therapeutic principle. Klin Padiatr. 213:285–287.10.1055/s-2001-17220
  • Wang Q, Perez JM, Webster TJ. 2013. Inhibited growth of Pseudomonas aeruginosa by dextran- and polyacrylic acid-coated ceria nanoparticles. Int J Nanome. 8:3395–3399.
  • Wiens JR, Vasil AI, Schurr MJ, Vasil ML. 2014. Iron-regulated expression of alginate production, mucoid phenotype, and biofilm formation by Pseudomonas aeruginosa. MBio. 5:e01010–01013.
  • Wu H, Lee B, Yang L, Wang H, Givskov M, Molin S, Hoiby N, Song Z. 2011. Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation. FEMS Immunol Med Microbiol. 62:49–56.10.1111/fim.2011.62.issue-1
  • Xie J, Huang J, Li X, Sun S, Chen X. 2009. Iron oxide nanoparticle platform for biomedical applications. Curr Med Chem. 16:1278–1294.10.2174/092986709787846604
  • Zhang S, Wei W, Zhang J, Mao Y, Liu S. 2002. Effect of static magnetic field on growth of Escherichia coli and relative response model of series piezoelectric quartz crystal. Analyst. 127:373–377.10.1039/b109617f

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.